Table 3.

Clinical and behavioral characteristics of patients and prevalence of Poor Controlled Glycemia of participants with diabetes mellitus, West Shewa, Ethiopia, 2020 (n = 390).

Variables	Category	Number	Percent	Outcome of Glycemic Control
				A1c ≥ 7% (%)	A1c<7% (%)
Diabetes Mellitus Type	T1DM	111	28.5	66 (59.5%)	45 (40.5%)
	T2DM	279	71.5	183 (65.6%)	96 (34.4%)
Duration of DM	<5yrs	207	53.1	130 (62.8%)	77 (37.2%)
	5–10yrs	107	27.4	68 (62.6%)	40 (37.4%)
	≥10yrs	76	19.5	52 (68.4%)	24 (31.6%)
Treatment regimen	Oral hypoglycemic agents	222	56.9	142 (64.0%)	80 (36.0%)
	Injection (Insulin)	129	33.1	83 (64.3%	46 (35.7%)
	Oral and injection	39	10.0	24 (61.5%)	15 (38.5%)
Statin treatment	Yes	37	9.5	22 (59.5%)	15 (40.5%)
	No	353	90.5	227 (64.3%)	126 (35.7%)
BMI (kg/m2)	Low (<18.5)	22	5.6	16 (35.7%)	6 (27.3%)
	Normal (18.5–24.9)	201	51.5	124 (61.7%)	77 (38.3%)
	Overweight (25–29.9)	126	32.3	82 (65.1%)	44 (34.9%)
	Obese (≥30)	41	10.5	27 (65.9%)	14 (34.1%)
Hypertension	Yes (≥140/90)	169	43.3	117 (69.2%)	52 (30.8%)
	No (<140/90)	221	56.7	132 (59.7%)	89 (40.3%)
Alcohol intake	Yes	133	34.1	80 (60.2%)	53 (39.8%)
	No	257	65.9	169 (65.8%)	88 (34.2%)
Smoking status	Yes	47	12.1	32 (68.1%)	15 (31.9%)
	No	343	87.9	162 (47.2%)	181 (52.8%)
Vigorous-intensity aerobic physical activity	Yes (≥75–150 min/week)	118	30.3	77 (65.3%)	41 (34.7%)
	No (<75–150 min/week)	272	69.7	172 (65.1%)	100 (36.8%)
Moderate-intensity aerobic physical activity	Yes(≥150–300 min/week)	141	36.2	97 (61.7%)	54 (38.3%
	No (<150–300 min/week)	249	63.8	162 (65.1%)	87 (34.9%)
Total cholesterol	<200 mg/dl (Normal)	276	70.8	169 (61.2%)	107 (38.8%)
	≥200 mg/dl (High)	114	29.2	80 (70.2%)	34 (29.8%)
Triglyceride	Normal (<150 mg/dl)	143	36.7	95 (66.4%)	48 (33.6%)
	High (≥150 mg/dl)	247	63.3	154 (62.3%)	93 (37.7%)
HDL-C	Normal (>60 mg/dl)	203	52.1	98 (68.0%)	32 (65.7%)
	Low (≤60 mg/dl)	187	47.9	111 (59.4%)	46 (40.6%)
LDL-C	Normal (<130 mg/dl)	325	83.3	196 (60.3%)	129 (39.7%)
	High (≥130 mg/dl)	65	16.7	53 (81.5%)	(18.5%)